Psyched: Medical Psychedelics In Davos, Canadian Sen Does Psychedelics, Ei.Ventures & Mycotopia To Merge Into $383M Company

Medical Psychedelics have made it into Davos, just in time for the World Economic Forum.

For the first time in its 51-year history, the world-renowned Davos meeting is including a Medical Psychedelics House as part of a series of parallel unofficial taking place on Davos’ main street.

Benzinga is present at the event, now going into its fourth, where representatives from all sectors of the psychedelics industry, academia and media are sharing their knowledge with members of the Davos crowd. It is truly a sight to behold.

Psychedelics continue to make headlines not just in Switzerland, but around the world. In Canada, Larry Campbell, a 74-year-old Canadian Senator admitted to having used psilocybin as part of a treatment to alleviate his depression.

In Australia, the National Science Agency will work with Australian med-tech companies to develop new psychedelics and enhance existing ones.

Medical Psychedelics Series At Davos To Showcase Clinical Efficacy Of Psychedelics To World Economic Forum Attendees

This year, Davos, Switzerland, will host some of the world’s most prominent psychedelic industry leaders and researchers in a separate satellite event that will run parallel to the World Economic Forum. From May 21 through 26, the Medical Psychedelic Series at Davos will feature…Read More…

Ei.Ventures And Mycotopia To Merge Into New Psychedelic Mushroom Company

Two companies in the psychedelics space have signed a definitive agreement to merge. Mycotopia Therapies Inc. (OTCPink: TPIA) and Ei.Ventures Inc. have executed a previously-announced agreement by which they’ll give birth to a new entity called, which will become the parent company…Read More…

Clearmind: Positive Preclinical Evidence For Flagship Psychedelic Molecule, Looks To Human Trials Before Year-End

Psychedelics biotech company Clearmind Medicine Inc. (OTC Pink: CMNDF) has published information pertaining to the safety and efficacy of its flagship molecule, called MEAI or CMND-100, after its pre-IND meeting with the Food and Drug Administration on Wednesday. MEAI is a proprietary psychedelic…Read More…

Patents In The Psychedelics Space: Good Or Bad? It's Complicated, Here's What The Experts Say

Patents are the golden eggs of the booming psychedelic space. In an industry that revolves around substances found in nature (such as psilocybin, ibogaine or DMT) or compounds whose patents have already expired (LSD and MDMA), new patents are the primary way in which companies can …Read More…

CSIRO, Australia's National Science Agency, Gets Into The Psychedelics Space

It’s not every day that a country’s national institute makes public its efforts to get into psychedelics, but today is one of those days. The Commonwealth Scientific and Industrial Research Organization (CSIRO) announced that it will work …

Full story available on

More Psyched: Medical Psychedelics In Davos, Canadian Sen Does Psychedelics, Ei.Ventures & Mycotopia To Merge Into $383M Company